Literature DB >> 9386718

Surgical management of invasive pulmonary aspergillosis in neutropenic patients.

A Bernard1, D Caillot, J F Couaillier, O Casasnovas, H Guy, J P Favre.   

Abstract

BACKGROUND: The aim of our study was to clarify the indications for operation in invasive pulmonary aspergillosis.
METHODS: Nineteen patients with hematologic malignancy, in whom invasive pulmonary aspergillosis developed during the course of neutropenia, had operations. Neutropenia lasted 28 days (range, 15 to 45 days). The preoperative diagnosis of invasive pulmonary aspergillosis was based on computed tomographic scan findings (halo or air crescent signs).
RESULTS: Eight patients underwent emergency operations, before marrow recovery, for prevention of massive hemoptysis. The criterion for operation was an aspergillosis lesion that contacted the pulmonary artery on computed tomography. A lobectomy was performed in all cases. A sleeve resection of the pulmonary artery was necessary on two occasions. There was one postoperative death due to extensive aspergillosis. The length of hospitalization after operation was 13 days (range, 6 to 18 days). Seven patients were treated by elective resection of a residual mass (before hematologic therapy in 6 cases). The types of resection performed were lobectomy (n = 4), lingulectomy (n = 1), and wedge resection (n = 2). There were no postoperative deaths. The average length of stay before discharge from the hospital was 11 days (range, 7 to 20 days). The surgical resection was performed as a diagnostic procedure in the 4 remaining patients after an allotted time of 14 days (range, 4 to 24 days) from initiation of antifungal therapy.
CONCLUSIONS: The combination of antifungal agents and surgical resection is an efficient strategy for the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancy.

Entities:  

Mesh:

Year:  1997        PMID: 9386718     DOI: 10.1016/S0003-4975(97)00858-8

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

Review 1.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

2.  Use of intravoxel incoherent motion diffusion-weighted MR imaging for assessment of treatment response to invasive fungal infection in the lung.

Authors:  Chenggong Yan; Jun Xu; Wei Xiong; Qi Wei; Ru Feng; Yuankui Wu; Qifa Liu; Caixia Li; Queenie Chan; Yikai Xu
Journal:  Eur Radiol       Date:  2016-05-14       Impact factor: 5.315

Review 3.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

4.  [Hemoptysis].

Authors:  L Freitag; H N Macha
Journal:  Internist (Berl)       Date:  2004-05       Impact factor: 0.743

5.  Invasive pulmonary aspergillosis: role of early diagnosis and surgical treatment in patients with acute leukemia.

Authors:  Ridvan Ali; Fahir Ozkalemkas; Tulay Ozcelik; Vildan Ozkocaman; Atilla Ozkan; Sami Bayram; Beyza Ener; Ahmet Ursavas; Guze Ozal; Ahmet Tunali
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-07-27       Impact factor: 3.944

6.  Successful management of gastropulmonary fistula due to invasive fungal infection after chemotherapy and autologous stem cell transplantation: a case report.

Authors:  Ričardas Janilionis; Lina Lukoševičiūtė; Virgilijus Beiša; Valdemaras Jotautas; Roberta Petrauskaitė; Valdas Pečeliūnas; Renata Jucaitienė
Journal:  Acta Med Litu       Date:  2016

Review 7.  Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients.

Authors:  Georg Maschmeyer; Antje Haas; Oliver A Cornely
Journal:  Drugs       Date:  2007       Impact factor: 11.431

8.  Invasive aspergillosis successfully treated by combined antifungal therapy and immunosuppressive monotherapy two months following heart transplantation.

Authors:  Tomasz Urbanowicz; Bartłomiej Żabicki; Hanna Baszyńska-Wachowiak; Ewa Straburzyńska-Migaj; Robert Juszkat; Stefan Grajek; Marek Jemielity
Journal:  Kardiochir Torakochirurgia Pol       Date:  2016-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.